84 related articles for article (PubMed ID: 11917573)
1. Effectiveness of mass screening for endometrial cancer.
Nakagawa-Okamura C; Sato S; Tsuji I; Kuramoto H; Tsubono Y; Aoki D; Jobo T; Oomura M; Hisamichi S; Yajima A
Acta Cytol; 2002; 46(2):277-83. PubMed ID: 11917573
[TBL] [Abstract][Full Text] [Related]
2. The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation.
Jolly S; Vargas CE; Kumar T; Weiner SA; Brabbins DS; Chen PY; Floyd W; Martinez AA
Gynecol Oncol; 2006 Oct; 103(1):87-93. PubMed ID: 16545441
[TBL] [Abstract][Full Text] [Related]
3. Frequency and effect of adjuvant radiation therapy among women with stage I endometrial adenocarcinoma.
Lee CM; Szabo A; Shrieve DC; Macdonald OK; Gaffney DK
JAMA; 2006 Jan; 295(4):389-97. PubMed ID: 16434629
[TBL] [Abstract][Full Text] [Related]
4. Survival after stage IA endometrial cancer; can follow-up be altered? A prospective nationwide Danish survey.
Lajer H; Elnegaard S; Christensen RD; Ortoft G; Schledermann DE; Mogensen O
Acta Obstet Gynecol Scand; 2012 Aug; 91(8):976-82. PubMed ID: 22548255
[TBL] [Abstract][Full Text] [Related]
5. Uterine body cancer mass screening at Tokai University Hospital.
Nagase E; Yasuda M; Kajiwara H; Osamura RY; Yoshitake T; Hirasawa T; Muramatsu T; Miyamoto T; Murakami M; Makino T; Ogawa T
Tokai J Exp Clin Med; 2004 Jun; 29(2):43-8. PubMed ID: 15473339
[TBL] [Abstract][Full Text] [Related]
6. Significance of adenomyosis on tumor progression and survival outcome of endometrial cancer.
Matsuo K; Cahoon SS; Gualtieri M; Scannell CA; Jung CE; Takano T; Paulson RJ; Muderspach LI; Roman LD
Ann Surg Oncol; 2014 Dec; 21(13):4246-55. PubMed ID: 25001096
[TBL] [Abstract][Full Text] [Related]
7. The impact on survival of two different staging strategies in apparent early stage endometrial cancer comparing sentinel lymph nodes mapping algorithm and selective lymphadenectomy: An Italian retrospective analysis of two reference centers.
Buda A; Di Martino G; Restaino S; De Ponti E; Monterossi G; Giuliani D; Ercoli A; Dell'Orto F; Dinoi G; Grassi T; Scambia G; Fanfani F
Gynecol Oncol; 2017 Dec; 147(3):528-534. PubMed ID: 29032824
[TBL] [Abstract][Full Text] [Related]
8. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
[TBL] [Abstract][Full Text] [Related]
9. Radiation-associated endometrial cancers are prognostically unfavorable tumors: a clinicopathologic comparison with 527 sporadic endometrial cancers.
Pothuri B; Ramondetta L; Eifel P; Deavers MT; Wilton A; Alektiar K; Barakat R; Soslow RA
Gynecol Oncol; 2006 Dec; 103(3):948-51. PubMed ID: 16870239
[TBL] [Abstract][Full Text] [Related]
10. Does the revised International Federation of Gynecology and Obstetrics staging system for endometrial cancer lead to increased discrimination in patient outcomes?
Cooke EW; Pappas L; Gaffney DK
Cancer; 2011 Sep; 117(18):4231-7. PubMed ID: 21387282
[TBL] [Abstract][Full Text] [Related]
11. The risk of diagnostic hysteroscopy in women with endometrial cancer.
Soucie JE; Chu PA; Ross S; Snodgrass T; Wood SL
Am J Obstet Gynecol; 2012 Jul; 207(1):71.e1-5. PubMed ID: 22621816
[TBL] [Abstract][Full Text] [Related]
12. Mass screening for cancer of the endometrium in Miyagi Prefecture, Japan.
Sato S; Matsunaga G; Konno R; Yajima A
Acta Cytol; 1998; 42(2):295-8. PubMed ID: 9568126
[TBL] [Abstract][Full Text] [Related]
13. Detection of recurrence in early stage endometrial cancer - the role of symptoms and routine follow-up.
Jeppesen MM; Mogensen O; Hansen DG; Iachina M; Korsholm M; Jensen PT
Acta Oncol; 2017 Feb; 56(2):262-269. PubMed ID: 28080157
[TBL] [Abstract][Full Text] [Related]
14. A comparative study on the efficacy of a mass screening program for colorectal cancer--comparison between cancer cases detected by mass screening and by outpatient clinics.
Nakama H
Asia Pac J Public Health; 1994; 7(3):159-64. PubMed ID: 7794654
[TBL] [Abstract][Full Text] [Related]
15. Brachytherapy Is Associated With Improved Survival in Inoperable Stage I Endometrial Adenocarcinoma: A Population-Based Analysis.
Acharya S; Perkins SM; DeWees T; Fischer-Valuck BW; Mutch DG; Powell MA; Schwarz JK; Grigsby PW
Int J Radiat Oncol Biol Phys; 2015 Nov; 93(3):649-57. PubMed ID: 26461007
[TBL] [Abstract][Full Text] [Related]
16. Stage IA vs. IB endometrial stromal sarcoma: does the new staging system predict survival?
Garg G; Shah JP; Toy EP; Bryant CS; Kumar S; Morris RT
Gynecol Oncol; 2010 Jul; 118(1):8-13. PubMed ID: 20447684
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of lymph node ratio and clinicopathologic parameters in patients diagnosed with stage IIIC endometrial cancer.
Polterauer S; Khalil S; Zivanovic O; Abu-Rustum NR; Hofstetter G; Concin N; Grimm C; Reinthaller A; Barakat RR; Leitao MM
Obstet Gynecol; 2012 Jun; 119(6):1210-8. PubMed ID: 22617586
[TBL] [Abstract][Full Text] [Related]
18. Endometrial carcinoma detected with SurePath liquid-based cervical cytology: comparison with conventional cytology.
Patel C; Ullal A; Roberts M; Brady J; Birch P; Bulmer JN; Wadehra V
Cytopathology; 2009 Dec; 20(6):380-7. PubMed ID: 19207308
[TBL] [Abstract][Full Text] [Related]
19. Clinical and pathologic correlates in surgical stage II endometrial carcinoma.
Cohn DE; Woeste EM; Cacchio S; Zanagnolo VL; Havrilesky LJ; Mariani A; Podratz KC; Huh WK; Whitworth JM; McMeekin DS; Powell MA; Boyd E; Phillips GS; Fowler JM
Obstet Gynecol; 2007 May; 109(5):1062-7. PubMed ID: 17470583
[TBL] [Abstract][Full Text] [Related]
20. Endometrial scraping cytology in women with extragenital malignancies.
Okadome M; Saito T; Tsukamoto N; Nishi K; Nishiyama N; Nagata E
Acta Cytol; 2006; 50(2):158-63. PubMed ID: 16610683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
